全文获取类型
收费全文 | 19593篇 |
免费 | 1117篇 |
国内免费 | 2124篇 |
出版年
2024年 | 53篇 |
2023年 | 448篇 |
2022年 | 461篇 |
2021年 | 636篇 |
2020年 | 709篇 |
2019年 | 1036篇 |
2018年 | 767篇 |
2017年 | 800篇 |
2016年 | 771篇 |
2015年 | 619篇 |
2014年 | 1056篇 |
2013年 | 1962篇 |
2012年 | 649篇 |
2011年 | 1084篇 |
2010年 | 706篇 |
2009年 | 1050篇 |
2008年 | 1080篇 |
2007年 | 1050篇 |
2006年 | 997篇 |
2005年 | 802篇 |
2004年 | 713篇 |
2003年 | 612篇 |
2002年 | 520篇 |
2001年 | 382篇 |
2000年 | 311篇 |
1999年 | 310篇 |
1998年 | 259篇 |
1997年 | 238篇 |
1996年 | 245篇 |
1995年 | 235篇 |
1994年 | 231篇 |
1993年 | 210篇 |
1992年 | 215篇 |
1991年 | 163篇 |
1990年 | 153篇 |
1989年 | 115篇 |
1988年 | 118篇 |
1987年 | 123篇 |
1986年 | 86篇 |
1985年 | 131篇 |
1984年 | 142篇 |
1983年 | 75篇 |
1982年 | 115篇 |
1981年 | 74篇 |
1980年 | 82篇 |
1979年 | 64篇 |
1978年 | 32篇 |
1977年 | 38篇 |
1976年 | 37篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 984 毫秒
941.
Xin Shi Yongqiang Deng Huajing Wang Guanghui Ji Wenlong Tan Tao Jiang 《MABS-AUSTIN》2016,8(3):574-584
Although dengue virus (DENV) infection severely threatens the health of humans, no specific antiviral drugs are currently approved for clinical use against DENV infection. Attachment and fusion are 2 critical steps for the flavivirus infection, and the corresponding functional epitopes are located at E protein domain III (E-DIII) and domain II (E-DII), respectively. Here, we constructed a bispecific antibody (DVD-1A1D-2A10) based on the 2 well-characterized anti-DENV monoclonal antibodies 1A1D-2 (1A1D) and 2A10G6 (2A10). The 1A1D antibody binds E-DIII and can block the virus attaching to the cell surface, while the 2A10 antibody binds E-DII and is able to prevent the virus from fusing with the endosomal membrane. Our data showed that DVD-1A1D-2A10 retained the antigen-binding activity of both parental antibodies. Importantly, it was demonstrated to be significantly more effective at neutralizing DENV than its parental antibodies both in vitro and in vivo, even better than the combination of them. To eliminate the potential antibody-dependent enhancement (ADE) effect, this bispecific antibody was successfully engineered to prevent Fc-γ-R interaction. Overall, we generated a bispecific anti-DENV antibody targeting both attachment and fusion stages, and this bispecific antibody broadly neutralized all 4 serotypes of DENV without risk of ADE, suggesting that it has great potential as a novel antiviral strategy against DENV. 相似文献
942.
943.
Rebeca Martínez Teresa Núñez de Villavicencio-Díaz Aniel Sánchez Yassel Ramos Jesús Noda Ferro Lázaro Gil González Milagros Méndez Elsa Rodríguez Ernesto Marcos Belinda Sánchez Yordanka Masforrol Hilda Garay Fernando Albericio Lisset Hermida Luis Javier González Eva Vonasek Mario P Estrada Vladimir Besada 《Biochemistry and Biophysics Reports》2016
BackgroundGrowth hormone secretagogues (GHS), among other factors, regulate the release of GH. The biological activity of the secretagogue peptide A233 as a promoter of growth and innate immunity in teleost fish has previously been demonstrated, but its role in the immune system of mammals is not well understood.MethodsThe effect of the peptide was investigated in J774A.2 macrophage cells using a comparative proteomics approach after 6 and 12 h of peptide stimulation.ResultsThe functional analysis of differentially modulated proteins showed that A233 peptide treatment appears to promote activation and ROS-dependent cytotoxic functions in macrophages and enhanced expression of antiviral protein complexes such as MAVS. In accordance with this hypothesis, we found that A233 treatment enhanced superoxide anion production and the IFN-γ level in J774A.2 cells and mouse splenocytes, respectively, and reduced viral load in a dengue virus mouse model of infection.ConclusionsThe growth hormone secretagogue A233 peptide promotes activation of ROS-dependent cytotoxic functions and exerts immunomodulatory effects that enable an antiviral state in a dengue virus mouse model.General SignificanceThe increase of IFN-γ level and the differential modulation of antiviral proteins by the A233 peptide suggest that the molecule could activate an innate immune response with a possible further impact in the treatment of acute and chronic diseases. 相似文献
944.
945.
【目的】开发出与铜绿假单胞菌粘肽合成酶PBP3有高亲和力,具有全新结构的先导化合物。【方法】以铜绿假单胞菌粘肽合成酶PBP3为靶点,通过分子对接软件DOCK6.5,对含有104万个小分子化合物的数据库进行了大规模虚拟筛选,选取结构相对简单的中选化合物进行合成,得到先导化合物,并验证其抑菌活性。【结果】通过grid score进行第一轮初筛,筛选出grid score分值小于–30 kcal/mol的6万个化合物,接着以amber score进行第二轮筛选,筛出amber score分值小于–20 kcal/mol的化合物约200个。最终,经过观察分析,从中挑选出4种打分高并且结构新颖的小分子化合物作为先导化合物。合成出的先导化合物及其衍生物对铜绿假单胞菌等常见微生物的最小抑菌浓度(MIC)在175–275μg/m L之间,对革兰氏阴性菌和阳性菌均有效,MIC值比作为阳性对照的磺胺嘧啶更低,说明先导化合物具有较好的抗菌活性。【结论】这些先导化合物可以进一步开发为新型抗菌药物,用于解决铜绿假单胞菌的耐药性问题。 相似文献
946.
【目的】阿尔茨海默症治疗药物石杉碱甲(Huperzine A,Hup A)的生物合成途径起始于赖氨酸脱羧酶(Lysine decarboxylase,LDC)。本研究克隆及表达了来源于产Hup A的植物内生真菌的LDC基因,并研究了其功能。【方法】采用RT-PCR扩增法,从一株产Hup A的蛇足石杉内生真菌Shiraia sp.Slf14获得LDC基因,构建表达质粒p ET-22b-LDC与p ET-32a-LDC,转化感受态细胞E.coli BL21,加入IPTG至终浓度为1×10~(–3) mol/L,于24°C、200 r/min培养8 h,诱导表达LDC蛋白质;通过Ni~(2+)金属亲和层析纯化重组LDC并建立酶促反应体系,利用TLC检测了LDC催化活性。利用生物信息学软件分析了LDC的理化性质及蛋白质的空间结构。【结果】成功克隆并异源表达出重组蛋白LDC与Trx-LDC,经SDS-PAGE电泳鉴定分子量分别为24.4 k Da和42.7 k Da,与预计大小相符。TLC结果表明LDC与Trx-LDC均具有赖氨酸脱羧酶活性。【结论】本研究从产Hup A的蛇足石杉内生真菌Shiraia sp.Slf14中成功克隆到LDC基因并进行了异源表达,检测到了其催化活性,为丰富LDC分子信息及阐明内生真菌中Hup A生物合成机制提供参考数据。 相似文献
947.
948.
949.
A fluorescence-based assay for the determination of lipase activity using rhodamine B as an indicator, and natural substrates such as olive oil, is described. It is based on the use of a rhodamine B–natural substrate emulsion in liquid state, which is advantageous over agar plate assays. This high-throughput method is simple and rapid and can be automated, making it suitable for screening and metagenomics application. Reaction conditions such as pH and temperature can be varied and controlled. Using triolein or olive oil as a natural substrate allows monitoring of lipase activity in reaction conditions that are closer to those used in industrial settings. The described method is sensitive over a wide range of product concentrations and offers good reproducibility. 相似文献
950.